The Management of Orthostatic Hypotension in Parkinson’s Disease
Open Access
- 1 January 2013
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 4, 64
Abstract
Orthostatic hypotension (OH) is a common and disabling symptom affecting Parkinson’s disease (PD) patients. We present the effect of the different therapies commonly used to manage PD on this clinical manifestation. For this purpose, we describe the relationship between OH and the current treatments employed in PD, such as L-DOPA, dopaminergic agonists, and continuous dopaminergic stimulation therapies. Additionally, we review the therapeutic measures that could be used to ameliorate OH. There are different approaches to deal with this manifestation, including pharmacological and non-pharmacological treatments, although none of them is specifically aimed for treating OH in PD.Keywords
This publication has 149 references indexed in Scilit:
- Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim resultsParkinsonism & Related Disorders, 2013
- Neurogenic orthostatic hypotension: pathophysiology, evaluation, and managementJournal of Neurology, 2012
- Factors related to orthostatic hypotension in Parkinson's diseaseParkinsonism & Related Disorders, 2012
- Prevalence of orthostatic hypotension in Parkinson’s disease: A systematic review and meta-analysisParkinsonism & Related Disorders, 2011
- Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (The Malmo Preventive Project)European Heart Journal, 2009
- Hypotension Unawareness in Profound Orthostatic HypotensionThe American Journal of Medicine, 2009
- Management of neurogenic orthostatic hypotension: an updateThe Lancet Neurology, 2008
- Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single doseJournal of the Neurological Sciences, 2007
- Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2006
- Orthostatic Hypotension in Patients with Parkinson??s DiseaseDrugs & Aging, 2001